 |
인쇄하기
취소
|
KFDA to review bio equivalency for 1,411 drugs in 2007.
The KFDA announced on June 25 that the 2007 bio equivalency review on the total 1,411 drugs of 20 different active ingredients including Gliclazide manufactured by 215 companies had been finally fixed.
However, the KFDA decided that over 1,500 drugs of 40 different ingredients which were supposed to nominated for the review in 2007 would be one year postponed to review in 2008.
The drugs ...
However, the KFDA decided that over 1,500 drugs of 40 different ingredients which were supposed to nominated for the review in 2007 would be one year postponed to review in 2008.
The drugs ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.